Name: Andy Doraiswamy

Country: united states


VP Operations and Quality, Oculeve

Email: Send an Email


357 Tehama Street Ste 1 San Francisco CA 94103

Research Interests:

Intraocular Lenses, Cataract, Refractive Surgery, Dry-Eye Diseases, Biomaterials, Drug-eluting, Accommodating IOLs


  • Andy is an experienced & accomplished innovator and leader in healthcare. 
  • He began his career in 3D rapid prototyping and Femto-second LASER technology. 
  • He led next-generation IOLs/medical devices at AVS, which was acquired by Santen Pharmaceuticals with material rights licensed to Bausch & Lomb (now Valeant).
  • Subsequently, Andy led Oculeve Inc., a start-up consumer health company spun-off from Stanford Biodesign, with a first-in-class connected neuromodulation technology. 
  • Funded by KPCB, NEA and Versant Ventures, Oculeve was acquired by Allergan Plc. for $125M plus milestones. 
  • Post-acquisition, he was retained by Allergan to lead the TrueTear/Oculeve program to key milestones.
  • Currently, Andy serves on the board of healthcare companies addressing various unmet clinical need. 
  • Andy earned his Ph.D. in BME from the School of Medicine at University of North Carolina-Chapel Hill, his Masters in MSE from University of Arizona, and his Bachelor’s degree in ChemE from University of Madras. 
  • He has co-authored more than 50 peer-reviewed publications and has presented at various venues on leadership and healthcare innovation.
  • Andy enjoys the benefits of meditation & the thrills of mountaineering. 
  • In his off-hours, he enjoys restoring and riding pre-WWII motorcycles. 
  • He is on a quest to climb the tallest mountains in the world and enjoys raising funds towards improving lives (